Similarly to AD patients, age was associated with a reduction in atrophy rate for MCI patients of 2 mL/y (0.60–3.19) for a 10-year increase in age after adjusting for WMH and APOE e4 and subtracting the age–atrophy effect in controls. This evidence concerns the gene APOE and Atrophy.